Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-11-045448)

Filing Details

Accession Number:: 0001140361-11-045448
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-09-12 13:26:33
Reporting Period:: 2011-09-06

Filing Date:: 2011-09-12
Accepted Time:: 2011-09-12 13:26:33
Original Submission Date:: 2011-09-09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1379006	Nanoviricides Inc.	NNVC.OB	Services-Commercial Physical & Biological Research (8731)	760674577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513285	Anil Diwan	135 Wood Street, Suite 205 West Haven CT 06516	President	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-09-06	15,000	$1.06	7,111,030	No	4	S	Direct
Common Stock	Disposition	2011-09-07	30,080	$1.07	7,080,950	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Does not include 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.
The purpose of this amendment is to amend the Form 4 filed on September 9, 2011 to correct a mathematical error in the shares owned by Anil Diwan following the transactions reported therein.